Late gadolinium enhancement as a potential marker of increased perioperative risk in aortic valve replacement
Open Access
- 17 April 2012
- journal article
- research article
- Published by Oxford University Press (OUP) in Interactive CardioVascular and Thoracic Surgery
- Vol. 15 (1), 45-50
- https://doi.org/10.1093/icvts/ivs098
Abstract
Risk assessment of patients with aortic stenosis (AS) undergoing aortic valve replacement (AVR) is challenging. We set out to determine the impact of myocardial late gadolinium enhancement (LGE), as detected by cardiovascular magnetic resonance (CMR), on postoperative outcomes following AVR. A prospective observational study was conducted on patients undergoing CMR using the LGE technique within 1 year of subsequent AVR. Patients were categorized into absent, mid-wall or infarct patterns of LGE by independent observers blinded to all clinical data, and data were collected with regard to 30-day mortality, major adverse cardiac and cerebrovascular events (MACCE) and postoperative complications. A total of 63 patients were studied. Twenty-five patients had no LGE; 20 had mid-wall LGE and 18 had an infarct pattern. The incidence of MACCE, cerebrovascular accident (CVA) and heart block were significantly higher in the mid-wall group compared with the other two groups (MACCE: 25 vs. 0 vs. 5%, P = 0.014; CVA: 20 vs. 0 vs. 0%, P = 0.013; heart block: 30 vs. 4 vs. 12%, P = 0.050). Patients with no LGE had no 30-day MACCE events and no deaths up to 2 years of follow-up. The myocardial LGE holds promise as a means of predicting risk prior to AVR for AS.Keywords
This publication has 13 references indexed in Scilit:
- Midwall Fibrosis Is an Independent Predictor of Mortality in Patients With Aortic StenosisJournal of the American College of Cardiology, 2011
- Prognostic Significance of Myocardial Fibrosis in Hypertrophic CardiomyopathyJournal of the American College of Cardiology, 2010
- Prognostic effect of inappropriately high left ventricular mass in asymptomatic severe aortic stenosisHeart, 2010
- Cardiovascular Magnetic Resonance, Fibrosis, and Prognosis in Dilated CardiomyopathyJournal of the American College of Cardiology, 2006
- ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease) Developed in Collaboration With the Society of Cardiovascular Anesthesiologists Endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic SurgeonsJournal of the American College of Cardiology, 2006
- Impact of Unrecognized Myocardial Scar Detected by Cardiac Magnetic Resonance Imaging on Event-Free Survival in Patients Presenting With Signs or Symptoms of Coronary Artery DiseaseCirculation, 2006
- Delayed hyperenhancement in magnetic resonance imaging of left ventricular hypertrophy caused by aortic stenosis and hypertrophic cardiomyopathy: visualisation of focal fibrosisHeart, 2006
- Left ventricular hypertrophy as a predictor of cardiovascular riskJournal of Hypertension, 2005
- Magnetic resonance to assess the aortic valve area in aortic stenosisJournal of the American College of Cardiology, 2004
- Gender differences in left ventricular functional response to aortic valve replacement.1994